Evoke Pharma, Inc. (EVOK)

USD 3.09

(6.19%)

Total Debt Summary of Evoke Pharma, Inc.

  • Evoke Pharma, Inc.'s latest annual total debt in 2023 was 5 Million USD , down -2.52% from previous year.
  • Evoke Pharma, Inc.'s latest quarterly total debt in 2024 Q2 was 5 Million USD , down 0.0% from previous quarter.
  • Evoke Pharma, Inc. reported annual total debt of 5.12 Million USD in 2022, up 2.33% from previous year.
  • Evoke Pharma, Inc. reported annual total debt of 5.01 Million USD in 2021, down -4.45% from previous year.
  • Evoke Pharma, Inc. reported quarterly total debt of 5 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Evoke Pharma, Inc. reported quarterly total debt of 5.05 Million USD for 2023 Q2, down -0.76% from previous quarter.

Annual Total Debt Chart of Evoke Pharma, Inc. (2023 - 2011)

Historical Annual Total Debt of Evoke Pharma, Inc. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 5 Million USD -2.52%
2022 5.12 Million USD 2.33%
2021 5.01 Million USD -4.45%
2020 5.24 Million USD 3686.6%
2019 138.53 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 4.37 Million USD -0.29%
2014 4.39 Million USD 48.67%
2013 2.95 Million USD 201.5%
2012 979.79 Thousand USD 0.0%
2011 - USD 0.0%

Peer Total Debt Comparison of Evoke Pharma, Inc.

Name Total Debt Total Debt Difference
Esperion Therapeutics, Inc. 540.94 Million USD 99.076%
Theratechnologies Inc. 58.96 Million USD 91.521%
Safety Shot Inc 1.54 Million USD -222.794%
Cosmos Health Inc. 12.42 Million USD 59.755%
Cronos Group Inc. 2.53 Million USD -96.855%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.301%
Kala Pharmaceuticals, Inc. 36.32 Million USD 86.235%
Organogenesis Holdings Inc. 119.35 Million USD 95.811%
Universe Pharmaceuticals INC 5.48 Million USD 8.8%
ProPhase Labs, Inc. 21.38 Million USD 76.614%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -722.368%
Dynavax Technologies Corporation 256.91 Million USD 98.054%
Radius Health, Inc. 365.31 Million USD 98.631%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -88.861%
Alvotech 1.07 Billion USD 99.535%
Sunshine Biopharma, Inc. 657.7 Thousand USD -660.219%
Alpha Teknova, Inc. 30.45 Million USD 83.584%
Intra-Cellular Therapies, Inc. 16.93 Million USD 70.481%
SCYNEXIS, Inc. 15.08 Million USD 66.844%
Harrow Health, Inc. 190.5 Million USD 97.375%
Biofrontera Inc. 5.39 Million USD 7.39%
DURECT Corporation 20.74 Million USD 75.899%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 87.96%
ANI Pharmaceuticals, Inc. 315.32 Million USD 98.414%
OptiNose, Inc. 131.74 Million USD 96.205%
RedHill Biopharma Ltd. 1.17 Million USD -326.255%
Aquestive Therapeutics, Inc. 98.82 Million USD 94.94%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 72.868%
SIGA Technologies, Inc. 1.46 Million USD -241.528%
Lifecore Biomedical, Inc. 130.36 Million USD 96.164%
Shineco, Inc. 29.65 Million USD 83.14%
Phibro Animal Health Corporation 525.45 Million USD 99.048%
Procaps Group S.A. 285.93 Million USD 98.251%
TherapeuticsMD, Inc. 8 Million USD 37.539%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -8260.225%
Viatris Inc. 18.12 Billion USD 99.972%
Sunshine Biopharma, Inc. 657.7 Thousand USD -660.219%
Rockwell Medical, Inc. 13.43 Million USD 62.795%
Incannex Healthcare Limited 373 Thousand USD -1240.483%
Aytu BioPharma, Inc. 15.12 Million USD 66.951%
Tilray Brands, Inc. 387.31 Million USD 98.709%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.258%
PetIQ, Inc. 468.3 Million USD 98.932%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 98.833%
Journey Medical Corporation 17.73 Million USD 71.799%
Alimera Sciences, Inc. 67.39 Million USD 92.581%
Petros Pharmaceuticals, Inc. 8.27 Million USD 39.589%
Assertio Holdings, Inc. 40.91 Million USD 87.779%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -359.688%
Embecta Corp. 1.63 Billion USD 99.695%
Cyclo Therapeutics, Inc. 1.03 Million USD -383.973%
Procaps Group, S.A. 285.93 Million USD 98.251%
PainReform Ltd. 86 Thousand USD -5713.953%
Avadel Pharmaceuticals plc 35.38 Million USD 85.869%
Hempacco Co., Inc. 13.72 Million USD 63.569%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 99.147%
Alvotech 1.07 Billion USD 99.535%
Lantheus Holdings, Inc. 616.94 Million USD 99.19%
Kamada Ltd. 8.74 Million USD 42.851%
Indivior PLC 281.6 Million USD 98.224%
Currenc Group, Inc. 31.94 Million USD 84.347%
Flora Growth Corp. 3.67 Million USD -36.166%
Cyclo Therapeutics, Inc. 1.03 Million USD -383.973%
Evolus, Inc. 126.54 Million USD 96.049%
HUTCHMED (China) Limited 86.13 Million USD 94.195%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.198%
Akanda Corp. 3.99 Million USD -25.038%